IT-system Development for Reaching Cervix Cancer Screening Non-attenders
Human Papillomavirus DNA Tests, Cervical Cancer
About this trial
This is an interventional prevention trial for Human Papillomavirus DNA Tests focused on measuring participation, self sampling, Screening
Eligibility Criteria
Inclusion Criteria:
- Non-participants in cervical cancer screening during a 10 year period
Exclusion Criteria:
- Active refusers
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Active Comparator
Active Comparator
Placebo Comparator
HPV self sampling test sent
HPV self sampling test ordered
Nurse navigator contact
Control
A Cobas PCR (polymerase chain reaction) Female swab sample Packet will be sent directly to women with a study invitation letter and instructions. Response rate will be measured.
An invitation to order a Cobas PCR Female swab sample Packet through an online application will be sent. Response rates will be measured.
An invitation to call the coordinating midwife with questions and concerns regarding screening will be sent. The coordinating midwife can help the participant order a Cobas PCR Female swab sample Packet or book a standard screening visit, if desired. Response rates will be measured
The standard, annual renewed invitation to cervical screening will be sent (control, routine practice). Response rate will be measured as a baseline.